Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $18 | $13 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $20 | $20 | $15 | $18 |
| Property Plant & Equip (Net) | $3 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $23 | $20 | $15 | $18 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $2 | $1 | $0 |
| Total Curr. Liab. | $9 | $4 | $1 | $0 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $10 | $4 | $2 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$75 | -$53 | -$38 | -$30 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $88 | $70 | $51 | $48 |
| Total Equity | $13 | $16 | $13 | $18 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | -$0 | $0 | $0 |
| Total Liab. & Tot. Equity | $23 | $20 | $15 | $18 |
| Net Debt | -$17 | -$18 | -$13 | -$18 |